This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$15.5M
Filings
108
Firms Hired
5
Active Period
2001–2014
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024.
2014 · first_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H. Con. Res. 96-- Establishing the budget for the U.S. Government for FY 2015 and setting forth appropriate budgetary levels for FY 2016 through 2024 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
Client expense: $440,000 · Firm income: —
Matched citations: H. Con. Res. 96
Protecting Access to Medicare Act of 2014
2014 · first_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
HR 4302 Protecting Access to Medicare Act of 2014 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
Client expense: $440,000 · Firm income: —
Matched citations: HR 4302
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the U.S. Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033. H. J. Res. 59 -- Continuing Appropriations Resolutions, 2014 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
Client expense: $280,000 · Firm income: —
Matched citations: H. Con. Res. 25
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the U.S. Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033. H. J. Res. 59 -- Continuing Appropriations Resolutions, 2014 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
Client expense: $280,000 · Firm income: —
Matched citations: H. Con. Res. 25
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the U.S. Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033. H. J. Res. 59 -- Continuing Appropriations Resolutions, 2014 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
Client expense: $280,000 · Firm income: —
Matched citations: H. J. Res. 59
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the U.S. Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033. H. J. Res. 59 -- Continuing Appropriations Resolutions, 2014 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
Client expense: $280,000 · Firm income: —
Matched citations: H. J. Res. 59
Safeguarding America's Pharmaceuticals Act of 2013
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
Client expense: $280,000 · Firm income: —
Matched citations: HR. 1919
VALID Compounding Act
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
Client expense: $280,000 · Firm income: —
Matched citations: HR 2186
Drug Quality and Security Act
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
Client expense: $280,000 · Firm income: —
Matched citations: HR 3204
Pharmaceutical Quality, Security, and Accountability Act
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
Client expense: $280,000 · Firm income: —
Matched citations: S. 959
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033 H. J. Res. 59 -- Continuing Appropriations Resolution, 2014In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
Client expense: $280,000 · Firm income: —
Matched citations: H. Con. Res. 25
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033 H. J. Res. 59 -- Continuing Appropriations Resolution, 2014In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
Client expense: $280,000 · Firm income: —
Matched citations: H. Con. Res. 25
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033 H. J. Res. 59 -- Continuing Appropriations Resolution, 2014In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
Client expense: $280,000 · Firm income: —
Matched citations: H. J. Res. 59
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033 H. J. Res. 59 -- Continuing Appropriations Resolution, 2014In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.
Client expense: $280,000 · Firm income: —
Matched citations: H. J. Res. 59
Safeguarding America's Pharmaceuticals Act of 2013
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
Client expense: $280,000 · Firm income: —
Matched citations: HR. 1919
VALID Compounding Act
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
Client expense: $280,000 · Firm income: —
Matched citations: HR 2186
Drug Quality and Security Act
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
Client expense: $280,000 · Firm income: —
Matched citations: HR 3204
Pharmaceutical Quality, Security, and Accountability Act
2013 · fourth_quarter · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
Client expense: $280,000 · Firm income: —
Matched citations: S. 959
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
2013 · fourth_quarter · Firm: SLC HEALTH STRATEGIES, LLC
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033 H. J. Res. 59 -- Continuing Appropriations Resolution, 2014 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs
Client expense: — · Firm income: $45,000
Matched citations: H. Con. Res. 25
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
2013 · fourth_quarter · Firm: SLC HEALTH STRATEGIES, LLC
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033 H. J. Res. 59 -- Continuing Appropriations Resolution, 2014 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs
Client expense: — · Firm income: $45,000
Matched citations: H. Con. Res. 25
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
2013 · fourth_quarter · Firm: SLC HEALTH STRATEGIES, LLC
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033 H. J. Res. 59 -- Continuing Appropriations Resolution, 2014 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs
Client expense: — · Firm income: $45,000
Matched citations: H. J. Res. 59
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
2013 · fourth_quarter · Firm: SLC HEALTH STRATEGIES, LLC
S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033 H. J. Res. 59 -- Continuing Appropriations Resolution, 2014 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs
Client expense: — · Firm income: $45,000
Matched citations: H. J. Res. 59
Safeguarding America's Pharmaceuticals Act of 2013
2013 · fourth_quarter · Firm: SLC HEALTH STRATEGIES, LLC
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
Client expense: — · Firm income: $45,000
Matched citations: HR. 1919
VALID Compounding Act
2013 · fourth_quarter · Firm: SLC HEALTH STRATEGIES, LLC
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
Client expense: — · Firm income: $45,000
Matched citations: HR 2186
Drug Quality and Security Act
2013 · fourth_quarter · Firm: SLC HEALTH STRATEGIES, LLC
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
Client expense: — · Firm income: $45,000
Matched citations: HR 3204
Source: Senate LDA